Related StoriesCornell biomedical engineers develop 'super natural killer cells' to destroy cancer cells in lymph nodesNew results reveal association between colorectal cancers and melanoma drug treatmentCrucial change in one DNA base predisposes kids to aggressive type of cancerRon Andrews, Clarient Vice Chairman and CEO, said, ‘Gaining allowance of these important patents represents another milestone for Clarient. Our technique of using our proprietary cancers biomarkers and correlating them to medical outcomes is paying down as we continue to develop novel diagnostic and prognostic checks.The nine hours of hearings ran the gamut of U.S. Priorities in nationwide security and foreign plan, McKitterick writes, adding, Congressional leaders appeared alarmed by reductions in global wellness spending and raised particular worries over the administration’s capability to fulfill its commitments to its PEPFAR objective of putting six million people on life-sustaining treatment by 2013. Secretary Clinton guaranteed the committees that cuts will be well balanced by consolidating applications, finding efficiencies, improving companions’ capacity, and shifting even more responsibilities to web host countries .This article was reprinted from kaiserhealthnews.org with permission from the Henry J.